Prevalence of HER-2 and Hormone Receptors and P53 Mutations in the Pathologic Specimens of Breast Cancer Patients

Table 1

Frequency of hormone receptors and breast cancer types.

Breast cancer types	Receptors types	Percent
IDC	ER/PR+	33%
	ER/PR−	56%
DCIS, mucinous carcinoma	HER-2+	82.4%
	HER-2−	84.6%
IDC,; medullary carcinoma	P53+	90%
	P53−	85.7%
medullary carcinoma,; ILC, and IDC	PR+	85.7%
	PR−	56%